UK-based biotech company Stablepharma has shown it can converts existing approved vaccines to fridge-free versions that can ...

One of the biggest barriers to people getting vaccines in some parts of the world is the ‘cold chain’ required to keep vaccines cold.

Stablepharma Ltd is a high-growth biotechnology company based in the UK and Spain, with the mission to reduce reliance on the ...

The work is being advanced within the NIHR Southampton Biomedical Research Center. Changes in breathing rate can often be the ...

The technology, made by biotechnology company Xgenera, was developed alongside scientists from the University of Southampton.

As part of the Plan for Change, the UK Government is prioritising cancer care to improve the NHS, including reducing waiting ...

www.southampton.ac.uk The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by: • Funding high ...

Patients could soon benefit from world-leading technology to diagnose bowel cancer earlier, faster, and cheaper, reducing the ...

Patients could benefit from new diagnostic technology designed to identify bowel cancer earlier, faster and more affordably. The innovation has been developed by a ...

David Stockley, NIHR BioResource Southampton Manager at UHS, said the volunteers would be playing a "vital role" in developing future healthcare provision. UHS said the study was set up as ...

Professor Samuele Cortese, senior lead author of the study, University of Southampton The study was funded by the National Institute for Health and Care Research (NIHR), within the framework of ...

A new study led by the University of Southampton has found that medications ... by the National Institute for Health and Care Research (NIHR), within the framework of the NIHR Research ...